智通财经APP讯，石四药集团(02005)发布公告，本集团的全量程C反应蛋白(hsCRP+常规CRP)检测试剂盒(萤光免疫层析法)及血清淀粉样蛋白A/C反应蛋白(SAA/CRP)检测试剂盒(萤光免疫层析法)两款医疗器械产品已获中国河北省药品监督管理局颁发医疗器械注册证。
全量程C反应蛋白(hsCRP+常规CRP)检测试剂盒用于体外定量检测人体样本全血、血清、血浆中C反应蛋白的含量，临床上用于非特异性炎症及心血管疾病的辅助诊断。血清淀粉样蛋白A/C反应蛋白(SAA/CRP)检测试剂盒用于体外定量检测人体血清/血浆/全血样本中的血清淀粉样蛋白A(SAA)和C反应蛋白(CRP)的含量，临床上用于非特异性炎症的辅助诊断。多款检测试剂盒的接连获批，为本集团打造医疗器械产品的新赛道。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.